[1] Chan AC, Cheung TT, Fan ST,et al. Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma[J].Ann Surg,2013, 257(4):686-692.
[2] Viggiani V, Palombi S, Gennarini G, et al. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients[J].Scand J Gastroenterol,2016, 51(10):1257.
[3] Mossad NA, Mahmoud EH, Osman EA, et al. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma[J].Tumor Biol,2014, 35(11):11559-11564.
[4] 中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版)[J].中华消化外科杂志, 2017, 16(7):705-720.
[5] 季婷婷, 林讷, 徐芳,等. PIVKA-Ⅱ在原发性肝癌中的诊断价值[J].肝胆胰外科杂志, 2015, 27(4):315-317.
[6] 陈齐林, 刘金兰. 原发性肝癌患者血浆中PIVKA-Ⅱ检测的意义[J].中国肿瘤临床, 1998, 25(1):38-40.
[7] 李丽芳, 刘桂林,李丹,等. 中西医结合治疗肝癌临床效果及对血清HA、AFU、GPC3、DCP水平影响[J].临床误诊误治, 2016, 29(6):62-64.
[8] 王智娜, 张春清, 王启志,等. 肝癌组织中Vasohibin1和HIF-1α表达及临床意义[J].胃肠病学和肝病学杂志, 2013, 22(7):628-631.
[9] 肖蕾, 毛睿, 杨颖,等. 高尔基体糖蛋白73、α-L-岩藻糖苷酶、甲胎蛋白单项检测与联合检测对原发性肝癌的诊断价值研究[J].中国全科医学, 2013, 16(14):1581-1583.
[10] 刘峰, 易继林, 李兴睿,等. Glut1和HIF-1α在原发性肝细胞癌中的表达和意义[J].中华普通外科杂志, 2007, 22(10):773-776.
[11] 林莺莺, 陈燕, 陈岩松,等. 异常凝血酶原(PIVKA-Ⅱ)检测在肝细胞癌中的临床价值[J].现代免疫学, 2015, 35(4):328-333.
[12] 秦亚楠, 洪雷, 宋正霞,等. 血清PIVKA-Ⅱ在原发性肝癌诊断中的应用[J].肝脏, 2017, 22(12):1103-1106. |
2019, Vol. 36 
